Annual Long Term Debt
$36.55 M
-$8.98 M-19.72%
31 December 2023
Summary:
Foghorn Therapeutics annual long term debt is currently $36.55 million, with the most recent change of -$8.98 million (-19.72%) on 31 December 2023. During the last 3 years, it has fallen by -$41.46 million (-53.14%). FHTX annual long term debt is now -53.14% below its all-time high of $78.02 million, reached on 31 December 2020.FHTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$30.30 M
-$2.24 M-6.89%
30 September 2024
Summary:
Foghorn Therapeutics quarterly long term debt is currently $30.30 million, with the most recent change of -$2.24 million (-6.89%) on 30 September 2024. Over the past year, it has dropped by -$8.41 million (-21.73%). FHTX quarterly long term debt is now -61.16% below its all-time high of $78.02 million, reached on 31 December 2020.FHTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.7% | -21.7% |
| 3 y3 years | -53.1% | -58.5% |
| 5 y5 years | +420.1% | - |
FHTX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -53.1% | at low | -58.5% | at low |
| 5 y | 5 years | -53.1% | +420.1% | -61.2% | +172.6% |
| alltime | all time | -53.1% | +420.1% | -61.2% | +172.6% |
Foghorn Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $30.30 M(-6.9%) |
| June 2024 | - | $32.54 M(-5.2%) |
| Mar 2024 | - | $34.31 M(-6.1%) |
| Dec 2023 | $36.55 M(-19.7%) | $36.55 M(-5.6%) |
| Sept 2023 | - | $38.71 M(-3.9%) |
| June 2023 | - | $40.27 M(-7.4%) |
| Mar 2023 | - | $43.49 M(-4.5%) |
| Dec 2022 | $45.54 M | $45.54 M(-2.1%) |
| Sept 2022 | - | $46.50 M(-5.4%) |
| June 2022 | - | $49.14 M(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $50.48 M(-1.7%) |
| Dec 2021 | $51.34 M(-34.2%) | $51.34 M(-29.6%) |
| Sept 2021 | - | $72.93 M(-2.5%) |
| June 2021 | - | $74.83 M(-2.2%) |
| Mar 2021 | - | $76.51 M(-1.9%) |
| Dec 2020 | $78.02 M(+601.8%) | $78.02 M(+20.4%) |
| Sept 2020 | - | $64.81 M(+7.4%) |
| June 2020 | - | $60.34 M(+442.7%) |
| Dec 2019 | $11.12 M(+58.2%) | $11.12 M |
| Dec 2018 | $7.03 M | - |
FAQ
- What is Foghorn Therapeutics annual long term debt?
- What is the all time high annual long term debt for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual long term debt year-on-year change?
- What is Foghorn Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly long term debt year-on-year change?
What is Foghorn Therapeutics annual long term debt?
The current annual long term debt of FHTX is $36.55 M
What is the all time high annual long term debt for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual long term debt is $78.02 M
What is Foghorn Therapeutics annual long term debt year-on-year change?
Over the past year, FHTX annual long term debt has changed by -$8.98 M (-19.72%)
What is Foghorn Therapeutics quarterly long term debt?
The current quarterly long term debt of FHTX is $30.30 M
What is the all time high quarterly long term debt for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly long term debt is $78.02 M
What is Foghorn Therapeutics quarterly long term debt year-on-year change?
Over the past year, FHTX quarterly long term debt has changed by -$8.41 M (-21.73%)